Linkou CGMHInternational Medicel CenterSite map

Update:2020/07/01

Primary appointment
Attending physician, Department of Radiation Oncology, Chang Gung Memorial Hospital – Linkou Medical Center
 
Specialty
Radiation therapy
Education
May 2012, College of Medicine, National Taiwan University
Academic appointment &Employment record
May 2012 ~ May 2013: Internship: National Taiwan University Hospital
Aug 2013 ~ July 2013: PGY-1: Far Eastern Memorial Hospital
Aug 2014 ~ July 2018: Residency: Department of Radiation Oncology, Chang Gung Memorial Hospital, Lin-kou branch, Taoyuan, Taiwan.
Membership in Scientific and Medical Societies
ECFMG
Licenses
PublicationPeer-Reviewed Original Research Articles
  1.  Chen PJ, Yap WK, Chang YC, Tseng CK, Chao YK, Hsieh CH, Pai PC, Lee CH, Yang CK, Ho TY, Hung TM. Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer. BMC Can-cer 20, 545 (2020). (SCI, IF: 2.933)
  2. Lin YH, Huang SM,Yap WK, Yang JW, Yeung L, Tsan DL, Chang TJ, Chen LC. Outcomes in patients with lacrimal gland carcinoma treated with definitive radiotherapy or eye-sparing surgery followed by adjuvant radiotherapy. Radiation Oncology 2020. (SCI, IF: 2.895)
  3.  Lin CH, Hung TM, Chang YC, Hsieh CH, Shih MC, Huang SM, Yang CK, Chang CF, Chan SC, Yap WK*. Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy. Cancers 2020, 12, 607. (SCI, IF: 6.102)
  4. Yap WK, Shih MC, Kuo C, Pai PC, Chou WC, Chang KP, Tsai MH, Tsang NM* Development and Validation of a Nomogram for Assessing Survival in Patients With Metastatic Lung Cancer Referred for Radiotherapy
for Bone Metastases. JAMA Network Open. 
2018;1(6):e183242. (SCI)
  5. Yap WK, Chang YC, Hsieh CH, Chao YK, Chen CC, Shih MC, Hung TM*. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 2018 May;45(5):689-698. (SCI, 2018 IF: 7.182, Radiology, Nuclear Medicine & Medical Imagings: 6/129)
  6. Yap WK, Chang YC, Tseng CK, Hsieh CH, Chao YK, Su PJ, Hou MM, Yang CK, Pai PC, Lin CR, Hsieh CE, Wu YY, Hung TM*. Predictive value of nodal maximum standardized uptake value of pretreatment [18F] fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer. Dis Esophagus. 2017 Aug 1;30(8):1-10. (SCI, 2018 IF: 2.323, Gastroenterology & Hepatology: 60/84) 
  7. Huang SM, Chen YC, Chen WY, Yang LY, Tsan DL, Tsang NM, Yap WK, Tsai CS, Leung WM, Hong JH, Chang JTC, Yeh TS, Wu TH, Chen YC, Lin YH, Huang BS*. Optimal Timing for Postsurgical Adjuvant Therapy in Patients with Gastric Cancer: A Propensity Score Matching Study. J Cancer 2019; 10(2):332-340. (SCI, 2018 IF: 3.182, Oncology: 105/229)
  8. Huang SM, Chen YC, Leung WM, Tsai CS, Fan KH, Hung TM, Yap WK, BS Huang*. Treatment outcome in patients with locally advanced gastric cancer receiving adjuvant chemoradiotherapy. Therapeutic Radiology and Oncology. 2017;24-1:1-11
Oral Presentations at International Conferences
  1. Taiwan Joint Cancer Conference 2016
  2. The 6th Japan-Taiwan Radiation Oncology Symposium 2018
Poster Presentations at International Conferences
  1. Taiwan Joint Cancer Conference 2016
  2. American Society for Radiation Oncology (ASTRO) meeting 2016, at Boston, USA
  3. Taiwan Joint Cancer Conference 2017
  4. The 5th Japan-Taiwan Radiation Oncology Symposium 2017, at Kobe, Japan.
  5. European Society for Radiotherapy & Oncology (ESTRO) Conference 2018, at Barcelona, Spain.
  6. The 6th Japan-Taiwan Radiation Oncology Symposium 2018
  7. American Society for Radiation Oncology (ASTRO) meeting 2018, at San Antonio, USA